Immune intervention with T regulatory cells: past lessons and future perspectives for type 1 diabetes.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Seminars in Immunology

• Publication date

  2011-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.smim.2011.07.007PMID 21831659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

  2011cited by this paper
• Natural and induced T CD4+CD25+FOXP3+ regulatory T cells.

  2011cited by this paper
• Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.

  2011cited by this paper
• Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial

  2011cited by this paper
• FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents.

  2011cited by this paper
• GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients.

  2011cited by this paper
• Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.

  2010cited by this paper
• Advances in the prediction and natural history of type 1 diabetes.

  2010cited by this paper
• Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy

  2010cited by this paper
• Clinical Impact of Suicide Gene Therapy in Allogeneic Hematopoietic Stem Cell Transplantation

  2010cited by this paper
• Stability of the Regulatory T Cell Lineage in Vivo

  2010cited by this paper
• Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites.

  2010cited by this paper
• Immunotherapy of type 1 diabetes: where are we and where should we be going?

  2010cited by this paper
• Genetics, pathogenesis and clinical interventions in type 1 diabetes

  2010cited by this paper
• Cutting Edge: Increased IL-17–Secreting T Cells in Children with New-Onset Type 1 Diabetes

  2010cited by this paper
• Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes

  2010cited by this paper
• Interleukin-2 receptor signaling: at the interface between tolerance and immunity.

  2010cited by this paper
• Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin

  2010cited by this paper
• IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells

  2010cited by this paper
• Failure to Preserve β-Cell Function With Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients With New- Onset Type 1 Diabetes

  2010cited by this paper
• Regulatory ripples

  2010cited by this paper
• Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN–JDRF Type 1 Diabetes Combination Therapy Assessment Group

  2010cited by this paper
• IFN-γ and IL-10 islet-antigen-specific T cell responses in autoantibody-negative first-degree relatives of patients with type 1 diabetes

  2010cited by this paper
• GAD-alum treatment in patients with type 1 diabetes and the subsequent effect on GADA IgG subclass distribution, GAD65 enzyme activity and humoral response.

  2010cited by this paper
• Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential

  2010cited by this paper
• Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3/GAD65 combination therapy in new-onset type 1 diabetes.

  2010cited by this paper
• Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass

  2010cited by this paper
• The inverse of immunity

  2010cited by this paper
• Potential T regulatory cell therapy in transplantation: how far have we come and how far can we go?

  2010cited by this paper
• Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases

  2010cited by this paper
• Human T regulatory cell therapy: take a billion or so and call me in the morning.

  2009cited by this paper
• First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells.

  2009cited by this paper
• The fate of human Treg cells.

  2009cited by this paper
• Defects in IL-2R Signaling Contribute to Diminished Maintenance of FOXP3 Expression in CD4+CD25+ Regulatory T-Cells of Type 1 Diabetic Subjects

  2009cited by this paper
• Autologous Umbilical Cord Blood Transfusion in Very Young Children With Type 1 Diabetes

  2009cited by this paper
• Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo

  2009cited by this paper
• Identification of IL-17-producing FOXP3+ regulatory T cells in humans

  2009cited by this paper
• Regulatory T cells and inhibitory cytokines in autoimmunity.

  2009cited by this paper
• Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.

  2009cited by this paper
• Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection.

  2009cited by this paper
• Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?

  2009cited by this paper
• Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

  2009cited by this paper
• Interactions between programmed death-1 and programmed death ligand-1 promote tolerance by blocking the T cell receptor-induced stop signal

  2009cited by this paper
• Antigen-Specific Dependence of Tr1-Cell Therapy in Preclinical Models of Islet Transplant

  2009cited by this paper
• Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes

  2009cited by this paper
• Rapamycin Prevents and Breaks the Anti-CD3–Induced Tolerance in NOD Mice

  2009cited by this paper
• GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes

  2009cited by this paper
• Immunotherapy for the Prevention and Treatment of Type 1 Diabetes

  2009cited by this paper
• Clinical grade preparation of human natural regulatory T‐cells encoding the thymidine kinase suicide gene as a safety gene: authors' reponse

  2009cited by this paper
• C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

  2009cited by this paper
• Therapeutic manipulation of immune tolerance in allergic disease

  2009cited by this paper
• GAD treatment and insulin secretion in recent-onset type 1 diabetes.

  2008cited by this paper
• TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function

  2008cited by this paper
• Clinical‐grade preparation of human natural regulatory T‐cells encoding the thymidine kinase suicide gene as a safety gene

  2008cited by this paper
• Islet antigen specific IL-10+ immune responses but not CD4+CD25+FoxP3+ cells at diagnosis predict glycemic control in type 1 diabetes.

  2008cited by this paper
• In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORγt+ T cells

  2008cited by this paper
• ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms

  2008cited by this paper
• Molecular antagonism and plasticity of regulatory and inflammatory T cell programs.

  2008cited by this paper
• Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity.

  2008cited by this paper
• Mitigation of Experimental Allergic Encephalomyelitis by TGF-β Induced Foxp3+ Regulatory T Lymphocytes through the Induction of Anergy and Infectious Tolerance1

  2008cited by this paper
• Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4+CD25+FOXP3+ Regulatory T-Cells

  2008cited by this paper
• Autologous umbilical cord blood infusion for type 1 diabetes.

  2008cited by this paper
• The Effector T Cells of Diabetic Subjects Are Resistant to Regulation via CD4+FOXP3+ Regulatory T Cells1

  2008cited by this paper
• Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned?

  2008cited by this paper
• Increased resistance to CD4+CD25hi regulatory T cell‐mediated suppression in patients with type 1 diabetes

  2008cited by this paper
• A dominant function for interleukin 27 in generating interleukin 10–producing anti-inflammatory T cells

  2007cited by this paper
• Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans

  2007cited by this paper
• At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+high T-Cell Fraction

  2007cited by this paper
• New reagents on the horizon for immune tolerance.

  2007cited by this paper
• Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease

  2007cited by this paper
• Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10

  2007cited by this paper
• Type 1 diabetes risk assessment: improvement by follow-up measurements in young islet autoantibody-positive relatives

  2006cited by this paper
• Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients1

  2006cited by this paper
• Induction of Tolerance in Type 1 Diabetes via Both CD4+CD25+ T Regulatory Cells and T Regulatory Type 1 Cells

  2006cited by this paper
• Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway

  2006cited by this paper
• CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

  2006cited by this paper
• Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.

  2006cited by this paper
• Erratum: Interleukin-10- secreting type 1 regulatory T cells in rodents and humans (Immunological Reviews (2006) 212, (28-50))

  2006cited by this paper
• Tr1 cells: from discovery to their clinical application.

  2006cited by this paper
• Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

  2006cited by this paper
• Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans

  2006cited by this paper
• The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity

  2005cited by this paper
• IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes.

  2005cited by this paper
• A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes

  2005cited by this paper
• Impact of IDDM2 on disease pathogenesis and progression in children with newly diagnosed type 1 diabetes: reduced insulin antibody titres and preserved beta cell function

  2005cited by this paper
• Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

  2005cited by this paper
• Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes.

  2005cited by this paper
• Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

  2005cited by this paper
• Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.

  2005cited by this paper
• Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

  2005cited by this paper
• ADA Outstanding Scientific Achievement Lecture 2004. Thirty years of investigating the autoimmune basis for type 1 diabetes: why can't we prevent or reverse this disease?

  2005cited by this paper
• Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes.

  2005cited by this paper
• Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

  2005cited by this paper
• Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

  2005cited by this paper
• CD4+CD25high regulatory T cells in human autoimmune diabetes.

  2005cited by this paper
• CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene.

  2004cited by this paper
• IL-10-Secreting Regulatory T Cells Do Not Express Foxp3 but Have Comparable Regulatory Function to Naturally Occurring CD4+CD25+ Regulatory T Cells 1

  2004cited by this paper
• Polyclonal anti-T-cell therapy for type 1 diabetes mellitus of recent onset.

  2004cited by this paper
• Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.

  2004cited by this paper
• TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes

  2003cited by this paper

• Modulation of CD8 Modulation of CD8 ++ T cell responses to AAV vectors with IgG-T cell responses to AAV vectors with IgG-derived MHC class II epitopes derived MHC class II epitopes

  2023cites this paper
• GABA and Combined GABA with GAD65-Alum Treatment Alters Th1 Cytokine Responses of PBMCs from Children with Recent-Onset Type 1 Diabetes

  2023cites this paper
• Modulation of CD8 Modulation of CD8 ++ T cell responses to AAV vectors with IgG- T cell responses to AAV vectors with IgG-derived MHC class II epitopes derived MHC class II epitopes

  2022cites this paper
• Gold Nanoparticles: Multifaceted Roles in the Management of Autoimmune Disorders

  2021cites this paper
• Encapsulated in Polyphenolic Microcapsules Dampening Antigen-Specific T Cell Responses with Antigens

  2020influential citation
• Dampening Antigen-Specific T Cell Responses with Antigens Encapsulated in Polyphenolic Microcapsules

  2020cites this paper
• Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways, regulation DC/Treg induced immune tolerance and improving gut microecology

  2019cites this paper
• Chronic Hepatitis C Infection Has No Effect on Peripheral CD4+CD25+ Tregulatory Cells in Patients with End-Stage Renal Disease

  2019cites this paper
• Chapter 2 Immunotherapy in Autoimmune Diabetes

  2018cites this paper
• Gene therapy and type 1 diabetes mellitus.

  2018cites this paper
• miRNAs: novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes

  2017cites this paper
• Immunotherapy in Autoimmune Diabetes

  2017cites this paper
• Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T 1 D patients Running head : dose-dependent low dose IL-2 immunoregulation

  2017cites this paper
• T-Regulatory Cell Subsets in Children with Type 1 Diabetes Mellitus: Relation to Control of the Disease.

  2017cites this paper
• The crossroads between cancer immunity and autoimmunity: antibodies to self antigens.

  2017cites this paper
• Tolerogenic nanoparticles inhibit T cell–mediated autoimmunity through SOCS2

  2016cites this paper
• Can Diabetes Heal?- From Observations to Perspectives.

  2016cites this paper
• Regulatory T Cells: Translational Immunology: Mechanisms and Pharmacologic Approaches

  2016cites this paper
• Regulatory T cells: balancing protection versus pathology.

  2016cites this paper
• Vaccination with a co‐expression DNA plasmid containing GAD65 fragment gene and IL‐10 gene induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes

  2016cites this paper
• Regulatory T cells in the immunotherapy of melanoma

  2015cites this paper
• Generation of Donor-specific T Regulatory Type 1 Cells From Patients on Dialysis for Cell Therapy After Kidney Transplantation

  2015cites this paper
• Pharmacodynamic Monitoring of Mammalian Target of Rapamycin Inhibition by Phosphoflow Cytometric Determination of p70S6 Kinase Activity

  2015cites this paper
• Type 1 diabetes and T regulatory cells.

  2015cites this paper
• Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.

  2015cites this paper
• CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance

  2015cites this paper
• Hurdles in therapy with regulatory T cells

  2015cites this paper
• Large-scale Isolation of Highly Pure “Untouched” Regulatory T Cells in a GMP Environment for Adoptive Cell Therapy

  2015cites this paper
• Identification of Differentially Expressed Genes in Pancreatic Regulatory T-Cell Survival

  2015cites this paper
• Perfil do estresse oxidativo em pacientes com diabetes mellitus do tipo 1 submetidos ao transplante autólogo de células-tronco hematopoéticas, em Ribeirão Preto, SP

  2015cites this paper
• Alteration of Regulatory T Cells in Type 1 Diabetes Mellitus: A Comprehensive Review

  2014cites this paper
• Tools and methods for identification and analysis of rare antigen-specific T lymphocytes.

  2014cites this paper
• Mechanisms of autoimmunity in human diseases: a critical review of current dogma

  2014cites this paper
• MYELOID CELLS IN AUTOIMMUNE DISEASES

  2014cites this paper
• T Lymphocytes as Tools in Diagnostics and Immunotoxicology

  2014cites this paper
• Foxp3+ Treg Expanded from Patients with Established Diabetes Reduce Helios Expression while Retaining Normal Function Compared to Healthy Individuals

  2013cites this paper
• Vaccine against autoimmune disease: antigen-specific immunotherapy.

  2013cites this paper
• Prevention and treatment of type 1 diabetes mellitus by the manipulation of invariant natural killer T cells

  2013cites this paper
• [Characteristics of T lymphocyte subpopulations].

  2013cites this paper
• Research using autologous cord blood — time for a policy change

  2013cites this paper
• Application of IgG-Derived Natural Treg Epitopes (IgG Tregitopes) to Antigen-Specific Tolerance Induction in a Murine Model of Type 1 Diabetes

  2013cites this paper
• The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications

  2013cites this paper
• Tolerogenic Vaccination Reduced Effector Memory CD4 T Cells and Induced Effector Memory Treg Cells for Type I Diabetes Treatment

  2013cites this paper
• Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes

  2013cites this paper
• CD4+ T Cells from IPEX Patients Convert into Functional and Stable Regulatory T Cells by FOXP3 Gene Transfer

  2013cites this paper
• Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load

  2013cites this paper
• Total coumarins from Urtica dentata Hand prevent murine autoimmune diabetes via suppression of the TLR4-signaling pathways.

  2013cites this paper
• Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study

  2013influential citation
• Regulatory T Cells and the Control of the Allergic Response

  2012cites this paper
• Functional plasticity in human FOXP3+ regulatory T cells

  2012influential citation
• Dendritic Cells Control CD4+CD25+ Treg Cell Suppressor Function In Vitro through Juxtacrine Delivery of IL-2

  2012cites this paper
• GAD65 An Immunomodulator in Type 1 Diabetes

  2012cites this paper
• Translating tolerogenic therapies to the clinic – where do we stand?

  2012cites this paper
• Human regulatory macrophages as a cell-based medicinal product

  2012cites this paper
• GAD 65 AS AN IMMUNOMODULATOR IN TYPE 1 DIABETES

  2012cites this paper
• Regulatory immune cells in transplantation

  2012cites this paper